BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.880
+0.010 (0.35%)
Apr 25, 2025, 4:00 PM EDT - Market closed
BioNexus Gene Lab Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Cash & Equivalents | 1.58 | 2.62 | 0.61 | 0.58 | 0.7 | Upgrade
|
| Short-Term Investments | 2.79 | 3.31 | 1.51 | 1.55 | 2.09 | Upgrade
|
| Cash & Short-Term Investments | 4.38 | 5.93 | 2.12 | 2.12 | 2.79 | Upgrade
|
| Cash Growth | -26.17% | 179.84% | -0.24% | -23.81% | 224.50% | Upgrade
|
| Accounts Receivable | 1.38 | 0.8 | 2.87 | 3.36 | 4 | Upgrade
|
| Other Receivables | 0.29 | 0.18 | 0.06 | 0.08 | 0.02 | Upgrade
|
| Receivables | 1.66 | 0.98 | 2.93 | 3.44 | 4.02 | Upgrade
|
| Inventory | 1.39 | 1.14 | 0.98 | 1.52 | 1.18 | Upgrade
|
| Other Current Assets | - | - | - | 0.07 | - | Upgrade
|
| Total Current Assets | 7.43 | 8.05 | 6.02 | 7.15 | 7.99 | Upgrade
|
| Property, Plant & Equipment | 1.74 | 1.65 | 1.57 | 1.68 | 1.85 | Upgrade
|
| Long-Term Investments | 1.27 | 1.7 | 1.15 | 0.75 | 0.28 | Upgrade
|
| Total Assets | 10.43 | 11.4 | 8.74 | 9.57 | 10.12 | Upgrade
|
| Accounts Payable | 1.5 | 1.4 | 1.86 | 2.01 | 3.17 | Upgrade
|
| Short-Term Debt | 0.02 | 0.01 | - | - | - | Upgrade
|
| Current Portion of Leases | 0.05 | 0.03 | 0.02 | 0.04 | 0.05 | Upgrade
|
| Current Income Taxes Payable | - | - | - | 0.1 | 0.06 | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.08 | - | Upgrade
|
| Other Current Liabilities | 0.38 | 0.18 | 0.13 | 0.1 | 0.1 | Upgrade
|
| Total Current Liabilities | 1.95 | 1.63 | 2 | 2.33 | 3.37 | Upgrade
|
| Long-Term Leases | 0.16 | 0.1 | 0.04 | 0.04 | 0.08 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 0.01 | 0.03 | 0.03 | 0 | Upgrade
|
| Total Liabilities | 2.11 | 1.74 | 2.08 | 2.39 | 3.45 | Upgrade
|
| Common Stock | 17.33 | 17.19 | 10.93 | 10.78 | 10.78 | Upgrade
|
| Retained Earnings | -3.44 | -1.84 | 1.16 | 1.51 | 0.76 | Upgrade
|
| Comprehensive Income & Other | -5.57 | -5.69 | -5.42 | -5.11 | -4.88 | Upgrade
|
| Shareholders' Equity | 8.32 | 9.66 | 6.67 | 7.18 | 6.66 | Upgrade
|
| Total Liabilities & Equity | 10.43 | 11.4 | 8.74 | 9.57 | 10.12 | Upgrade
|
| Total Debt | 0.23 | 0.15 | 0.06 | 0.08 | 0.12 | Upgrade
|
| Net Cash (Debt) | 4.15 | 5.78 | 2.06 | 2.05 | 2.66 | Upgrade
|
| Net Cash Growth | -28.24% | 180.43% | 0.74% | -23.17% | 246.17% | Upgrade
|
| Net Cash Per Share | 2.33 | 3.64 | 1.43 | 1.43 | 3.11 | Upgrade
|
| Filing Date Shares Outstanding | 1.8 | 1.77 | 1.45 | 1.43 | 1.43 | Upgrade
|
| Total Common Shares Outstanding | 1.8 | 1.77 | 1.45 | 1.43 | 1.43 | Upgrade
|
| Working Capital | 5.48 | 6.42 | 4.02 | 4.82 | 4.61 | Upgrade
|
| Book Value Per Share | 4.63 | 5.47 | 4.60 | 5.03 | 4.67 | Upgrade
|
| Tangible Book Value | 8.32 | 9.66 | 6.67 | 7.18 | 6.66 | Upgrade
|
| Tangible Book Value Per Share | 4.63 | 5.47 | 4.60 | 5.03 | 4.67 | Upgrade
|
| Land | 1.51 | 1.51 | 1.51 | 1.51 | 1.51 | Upgrade
|
| Machinery | 0.88 | 0.68 | 0.65 | 0.59 | 0.59 | Upgrade
|
| Construction In Progress | - | 0.11 | - | - | - | Upgrade
|
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.